Prostate cancer screening: Continued controversies and novel biomarker advancements
Abstract. Prostate cancer (PCa) screening remains one of the most controversial topics in clinical and public health. Despite being the second most common cancer in men worldwide, recommendations for screening using prostate-specific antigen (PSA) are unclear. Early detection and the resulting posts...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health
2022-12-01
|
Series: | Current Urology |
Online Access: | http://journals.lww.com/10.1097/CU9.0000000000000145 |